Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 PharmGKB summary: very important pharmacogene information for PTGS2.

Literature DB >> 21063235

PharmGKB summary: very important pharmacogene information for PTGS2.

Caroline F Thorn¹, Tilo Grosser, Teri E Klein, Russ B Altman.

Abstract

Entities: CellLine Chemical Disease Gene Mutation Species

Mesh：

Substances：

Year: 2011 PMID： 21063235 PMCID： PMC3141084 DOI： 10.1097/FPC.0b013e3283415515

Source DB: PubMed Journal: Pharmacogenet Genomics ISSN： 1744-6872 Impact factor: 2.089

× No keyword cloud information.

79 in total

1. The Protein Data Bank.

Authors: H M Berman; J Westbrook; Z Feng; G Gilliland; T N Bhat; H Weissig; I N Shindyalov; P E Bourne
Journal: Nucleic Acids Res Date: 2000-01-01 Impact factor: 16.971

Review 2. Unresolved issues in the role of cyclooxygenase-2 in normal physiologic processes and disease.

Authors: P E Lipsky; P Brooks; L J Crofford; R DuBois; D Graham; L S Simon; L B van de Putte; S B Abramson
Journal: Arch Intern Med Date: 2000-04-10

3. Role of cyclooxygenase-2 and 5-lipoxygenase polymorphisms in Alzheimer's disease in a population from northern Italy: implication for pharmacogenomics.

Authors: Florinda Listì; Calogero Caruso; Domenico Lio; Giuseppina Colonna-Romano; Martina Chiappelli; Federico Licastro; Giuseppina Candore
Journal: J Alzheimers Dis Date: 2010 Impact factor: 4.472

Review 4. Emotion recollected in tranquility: lessons learned from the COX-2 saga.

Authors: Tilo Grosser; Ying Yu; Garret A Fitzgerald
Journal: Annu Rev Med Date: 2010 Impact factor: 13.739

5. Dexamethasone destabilizes cyclooxygenase 2 mRNA by inhibiting mitogen-activated protein kinase p38.

Authors: M Lasa; M Brook; J Saklatvala; A R Clark
Journal: Mol Cell Biol Date: 2001-02 Impact factor: 4.272

Review 6. Many actions of cyclooxygenase-2 in cellular dynamics and in cancer.

Authors: Yang Cao; Stephen M Prescott
Journal: J Cell Physiol Date: 2002-03 Impact factor: 6.384

7. Cyclooxygenase-2-dependent prostacyclin formation and blood pressure homeostasis: targeted exchange of cyclooxygenase isoforms in mice.

Authors: Ying Yu; Jane Stubbe; Salam Ibrahim; Wen-liang Song; Emer M Smyth; Emer M Symth; Colin D Funk; Garret A FitzGerald
Journal: Circ Res Date: 2009-11-25 Impact factor: 17.367

8. The influence of COX-2 single nucleotide polymorphisms on abdominal aortic aneurysm development and the associated inflammation.

Authors: Stephen A Badger; Chee V Soong; Ian S Young; Ann McGinty; Caroline Mercer; Anneq E Hughes
Journal: Angiology Date: 2009-07-21 Impact factor: 3.619

9. Associations between COX-2 polymorphisms, blood cholesterol and risk of acute coronary syndrome.

Authors: Ulla Vogel; Stine Segel; Claus Dethlefsen; Anne Tjønneland; Anne Thoustrup Saber; Håkan Wallin; Majken K Jensen; Erik B Schmidt; Paal Skytt Andersen; Kim Overvad
Journal: Atherosclerosis Date: 2009-08-28 Impact factor: 5.162

10. Failure of ductus arteriosus closure and remodeling in neonatal mice deficient in cyclooxygenase-1 and cyclooxygenase-2.

Authors: C D Loftin; D B Trivedi; H F Tiano; J A Clark; C A Lee; J A Epstein; S G Morham; M D Breyer; M Nguyen; B M Hawkins; J L Goulet; O Smithies; B H Koller; R Langenbach
Journal: Proc Natl Acad Sci U S A Date: 2001-01-23 Impact factor: 11.205

4 in total

Review 1. From pharmacogenomic knowledge acquisition to clinical applications: the PharmGKB as a clinical pharmacogenomic biomarker resource.

Authors: Ellen M McDonagh; Michelle Whirl-Carrillo; Yael Garten; Russ B Altman; Teri E Klein
Journal: Biomark Med Date: 2011-12 Impact factor: 2.851